Financial News
All News about Crispr Therapeutics Ag
![](https://cdn.benzinga.com/files/images/story/2023/CathieWoods-CourtesyArkInvest_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/758692/scientist-examines-samples-with-microscope-while-in-laboratory.jpg)
![](https://g.foolcdn.com/editorial/images/759041/gettyimages-friends-new-years.jpg)
![](https://g.foolcdn.com/editorial/images/758888/a-person-delivering-a-presentation-getty.jpg)
![](https://g.foolcdn.com/editorial/images/758499/scientists-studying-dna.jpg)
![](https://g.foolcdn.com/editorial/images/757823/people-discussing-a-sales-report.jpg)
![](https://g.foolcdn.com/editorial/images/758279/crsp.jpg)
![](https://g.foolcdn.com/editorial/images/758640/dna-on-monitor-scientists.jpg)
![](https://g.foolcdn.com/editorial/images/758783/gettyimages-two-researchers-work-in-a-lab.jpg)
![](https://investorplace.com/wp-content/uploads/2021/11/crispr-theraputics-crsp-stock-1600.jpg)
![](https://g.foolcdn.com/editorial/images/758605/investors-look-at-tablet-outside.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://g.foolcdn.com/editorial/images/758708/growth-trend.jpg)
![](https://g.foolcdn.com/editorial/images/758604/gettyimages-474008420.jpg)
![](https://g.foolcdn.com/editorial/images/758556/gettyimages-1139299116.jpg)
![](https://g.foolcdn.com/editorial/images/757594/person-sitting-and-working-at-a-desk.jpg)
![](https://g.foolcdn.com/editorial/images/758106/concerned-investor-with-two-people-in-background.jpg)
![](https://g.foolcdn.com/editorial/images/758336/santa-claus-buggy-chart.jpg)
![](https://g.foolcdn.com/editorial/images/758246/dna-scientist-test-tube.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/small-cap-stocks-to-consider.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coin-stock-1.jpg)
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
December 14, 2023
Via InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://g.foolcdn.com/editorial/images/758114/innovation.jpg)
![](https://g.foolcdn.com/editorial/images/758050/biotech.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie-Wood-Ark-Invest_1.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/12/q8qy2w7S.jpg)
![](https://g.foolcdn.com/editorial/images/757864/gettyimages-research-team-smiles-in-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie-Wood-Ark-Photo-courtesy-Benzinga-_2.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/757908/scientists-study-strands-of-dna.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.